Challenges associated with hypertensive disease during pregnancy in low-income countries

International Journal of Gynecology and Obstetrics

Volumn 110, Issue 1, 2010, Pages 78-81

  Danso, Kwabena A ^a,b   Opare Addo, Henry S ^a,b  

^a KWAME NKRUMAH UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Ghana)

^b KOMFO ANOKYE TEACHING HOSPITAL   (Ghana)

Author keywords

Eclampsia; Hypertensive disease in pregnancy; Low income countries; Magnesium sulfate; Pre eclampsia

Indexed keywords

ACETYLSALICYLIC ACID; ATENOLOL; HYDRALAZINE; LABETALOL; MAGNESIUM SULFATE; METHYLDOPA; NIFEDIPINE; UBIDECARENONE; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT;

ARTICLE; BLOOD PRESSURE MONITORING; CLINICAL TRIAL; DRUG CHOICE; DRUG COST; DRUG EFFICACY; DRUG SAFETY; ECLAMPSIA; EVIDENCE BASED MEDICINE; FETOTOXICITY; HIGH RISK PREGNANCY; HUMAN; LOW DRUG DOSE; LOWEST INCOME GROUP; MATERNAL HYPERTENSION; MATERNAL MORTALITY; PREECLAMPSIA; PREGNANCY OUTCOME; PRIMARY PREVENTION; PRIORITY JOURNAL; PROTEINURIA; RISK REDUCTION; SCREENING TEST; SEIZURE; DEVELOPING COUNTRY; FEMALE; HYPERTENSION, PREGNANCY-INDUCED; PREGNANCY;

ANTICONVULSANTS; ANTIHYPERTENSIVE AGENTS; DEVELOPING COUNTRIES; ECLAMPSIA; FEMALE; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; MAGNESIUM SULFATE; PREGNANCY;

EID: 77953025894     PISSN: 00207292     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijgo.2010.01.026     Document Type: Article

References (25)

1. National High Blood Pressure Education Program Working Group Report on High Blood Pressure in Pregnancy. Am J Obstet Gynecol 163 5 Pt 1 (1990) 1691-1712
2. ACOG Committee on Obstetric Practice. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. Int J Gynecol Obstet 77 1 (2002) 67-75
3. Duley L. Maternal mortality associated with hypertensive disorders of pregnancy in Africa, Asia, Latin America and the Caribbean. Br J Obstet Gynaecol 99 7 (1992) 547-553
4. Langer A., Villar J., Tell K., Kim T., and Kennedy S. Reducing eclampsia-related deaths-a call to action. Lancet 371 9614 (2008) 705-706
5. Igberase G.O., and Ebeigbe P.N. Eclampsia: ten-years of experience in a rural tertiary hospital in the Niger delta, Nigeria. J Obstet Gynaecol 26 5 (2006) 414-417
6. Khan K.S., Wojdyla D., Say L., Gülmezoglu A.M., and Van Look P.F. WHO analysis of causes of maternal death: a systematic review. Lancet 367 9516 (2006) 1066-1074
7. Villar J., Say L., Shennan A., Lindheimer M., Duley L., Conde-Agudelo A., et al. Methodological and technical issues related to the diagnosis, screening, prevention, and treatment of pre-eclampsia and eclampsia. Int J Gynecol Obstet 85 Suppl 1 (2004) S28-S41
8. Helewa M.E., Burrows R.F., Smith J., Williams K., Brain P., and Rabkin S.W. Report of the Canadian Hypertension Society Consensus Conference: 1. Definitions, evaluation and classification of hypertensive disorders in pregnancy. CMAJ 157 6 (1997) 715-725
9. Waugh J., Kilby M., Lambert P., Bell S.C., Blackwell C.N., Shennan A., et al. Validation of the DCA 2000 microalbumin:creatinine ratio urinanalyzer for its use in pregnancy and preeclampsia. Hypertens Pregnancy 22 1 (2003) 77-92
10. Ferrer R.L., Sibai B.M., Mulrow C.D., Chiquette E., Stevens K.R., and Cornell J. Management of mild chronic hypertension during pregnancy: a review. Obstet Gynecol 96 5 Pt 2 (2000) 849-860
11. Conde-Agudelo A., Villar J., and Lindheimer M. World Health Organization systematic review of screening tests for preeclampsia. Obstet Gynecol 104 6 (2004) 1367-1391
12. Kwawukume E.Y., and Ghosh T.S. Oral nifedipine therapy in the management of severe preeclampsia. Int J Gynecol Obstet 49 3 (1995) 265-269
13. Ferrer R.L., and Mulrow C.D. What if my Hypertensive Patient Becomes Pregnant?. In: Mulrow C.D. (Ed). Evidence-based Hypertension (2001), BMJ Publishing Group, London, UK 214-231
14. von Dadelszen P., Ornstein M.P., Bull S.B., Logan A.G., Koren G., and Magee L.A. Fall in mean arterial pressure and fetal growth restriction in pregnancy hypertension: a meta-analysis. Lancet 355 9198 (2000) 87-92
15. Walker J.J. Pre-eclampsia. Lancet 356 9237 (2000) 1260-1265
16. Duley L., Meher S., and Abalos E. Management of pre-eclampsia. BMJ 332 7539 (2006) 463-468
17. Wei S.Q., Xu H., Xiong X., Luo Z.C., Audibert F., and Fraser W.D. Tea consumption during pregnancy and the risk of pre-eclampsia. Int J Gynecol Obstet 105 2 (2009) 123-126
18. Teran E., Hernandez I., Nieto B., Tavara R., Ocampo J.E., and Calle A. Coenzyme Q10 supplementation during pregnancy reduces the risk of pre-eclampsia. Int J Gynecol Obstet 105 1 (2009) 43-45
19. Duley L., Henderson-Smart D.J., Meher S., and King J.F. Antiplatelet agents for preventing pre-eclampsia and its complications. Cochrane Database Syst Rev 2 (2007) CD004659
20. Jack B.W., and Culpepper L. Preconception care. Risk reduction and health promotion in preparation for pregnancy. JAMA 264 9 (1990) 1147-1149
21. Duckitt K., and Harrington D. Risk factors for pre-eclampsia at antenatal booking: systematic review of controlled studies. BMJ 330 7491 (2005) 565
22. Which anticonvulsant for women with eclampsia? Evidence from the Collaborative Eclampsia Trial. Lancet 345 8963 (1995) 1455-1463
23. Altman D., Carroli G., Duley L., Farrell B., Moodley J., Neilson J., et al. Magpie Trial Collaboration Group. Do women with pre-eclampsia, and their babies, benefit from magnesium sulphate? The Magpie Trial: a randomised placebo-controlled trial. Lancet 359 9321 (2002) 1877-1890
24. Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for women at 2 years. BJOG 114 3 (2007) 300-309
25. Magpie Trial Follow-Up Study Collaborative Group. The Magpie Trial: a randomised trial comparing magnesium sulphate with placebo for pre-eclampsia. Outcome for children at 18 months. BJOG 114 3 (2007) 289-299